Andrew Kenneth William Powell - 23 Nov 2021 Form 4 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-fact
Issuer symbol
ACRS
Transactions as of
23 Nov 2021
Net transactions value
$0
Form type
4
Filing time
03 Dec 2021, 15:52:54 UTC
Previous filing
08 Jun 2021
Next filing
02 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRS Common Stock Gift $0 -5,500 -33% $0.000000 11,209 23 Nov 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.